Patent · US Expired

Anti-sickling hemoglobin

US5877288A · kind A · utility

4Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 1994
Grant dateMar 2, 1999
Priority date
Expiry dateJun 17, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are anti-sickling human hemoglobins for use as sickle cell anemia therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.